// App-Quantinova.ai

OA0022 : The cambridge peanut allergy clinic: Real world safety and efficacy outcomes during oral immunotherapy with characterised peanut flour

Researchers

Presenter

  • Clark A

Principal Investigators

  • Zolkipli Q

  • Ewan P

Medical Centers

  • Cambridge University Hospitals, Cambridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • Glomeruloid microvascular proliferation

Drug/Treatment

  • Epinephrine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A